Skip to main content

Day: June 8, 2021

Pacira BioSciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021

— EXPAREL average daily sales for May 2021 were 162% of May 2020 — — EXPAREL momentum continues with average daily sales for May 2021 at 105% of April 2021 — PARSIPPANY, N.J., June 08, 2021 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported preliminary unaudited net product sales of EXPAREL® (bupivacaine liposome injectable suspension) and iovera° of $41.2 million and $1.0 million, respectively, for the month of May 2021. EXPAREL average daily sales for the month of May 2021 were 162 percent of May 2020 and 105 percent of April 2021. Sales in May 2020 were negatively impacted by significant restrictions that were in place for elective procedures due to the COVID-19 pandemic.        “EXPAREL...

Continue reading

Jenny Killeen Joins Cowen as Head of Human Resources

Industry veteran Jane Gerhard retiring NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that Jenny Killeen has joined the company as Managing Director, Head of Human Resources, succeeding Jane Gerhard, who is retiring from the Company. In her role, Ms. Killeen will be responsible for the Company’s people strategy, including talent acquisition, retention and development. In addition, Ms. Killeen is joining Cowen’s Management Committee, comprised of senior executives from across the organization and responsible for the development and execution of Cowen’s long-term strategy. She will be based in New York and will have a dual reporting line to Jeffrey M. Solomon, Chief Executive Officer, and John Holmes, Chief Operating Officer. “At Cowen, our people are our greatest asset,”...

Continue reading

Orezone Intersects 32 m of 3.87 g/t Gold Including 6 m of 14.40 g/t Gold and Identifies Near Surface High-Grade Gold Mineralization Outside of Reserves at Bomboré

Figure 1P17 Area Plan MapFigure 2P17 Long Section 730270 EVANCOUVER, British Columbia, June 08, 2021 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX.V: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased to announce initial results from its ongoing drilling program to test the expansion potential at the P17S deposit at its Bomboré Gold Project, located in Burkina Faso. The drilling program has been very successful returning the best hole to date at P17S with several other wide, multigram gold intercepts near surface outside of the current reserves and resource envelopes (see Figure 1). These drill results intersected multiple high-grade stacked zones of mineralization to the north of the P17S reserves including a new wide, shallowly dipping zone with excellent down-plunge continuity (see...

Continue reading

Summit Bank Selects the nCino Bank Operating System® to Enhance Commercial Offerings

nCino’s robust, cloud-based platform to provide a seamless application experience for forward-looking Pacific-Northwest Bank WILMINGTON, N.C., June 08, 2021 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced that $761 million-asset, Oregon-based Summit Bank selected nCino’s Bank Operating System to transform its operations and digitize its commercial lending business. Summit Bank will be utilizing nCino’s Commercial Banking and Automated Spreading solutions to empower the bank to gain insights faster and make proactive, impactful decisions that best serve its client base. nCino’s Automated Spreading, powered by nCino IQ (nIQ), can seamlessly spread financials to accurately and efficiently automate tasks and provide...

Continue reading

InflaRx Doses First Patient in Multicenter Phase II Clinical Trial in Cutaneous Squamous Cell Carcinoma with Vilobelimab

Proof-of-concept trial will evaluate vilobelimab alone and in combination with pembrolizumabJENA, Germany, June 08, 2021 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, today announced the enrollment of the first patient in an open-label, multicenter Phase II clinical study evaluating vilobelimab alone and in combination with pembrolizumab in patients with PD-1 or PD-L1 inhibitor resistant/refractory locally advanced or metastatic cutaneous squamous cell carcinoma (cSCC). The Phase II clinical trial is expected to enroll approximately 70 patients at sites in Europe, the U.S. and elsewhere. The study will investigate two independent arms: vilobelimab alone and vilobelimab in combination with pembrolizumab....

Continue reading

Vision Marine Technologies, Inc. Acquires EB Rental Ltd., Bolstering its Brand with Entry into a Burgeoning US Addressable Market

With this strategic vertically integrated acquisition, Vision Marine will have the unique advantage of further showcasing its proprietary new E-Motion™ powertrain system MONTREAL, June 08, 2021 (GLOBE NEWSWIRE) — Vision Marine Technologies, Inc. (Nasdaq: VMAR) (“Vision Marine” or the “Company”), a leading manufacturer within the electric recreational boating industry, is pleased to announce the acquisition of EB Rental Ltd. (“EBR”) consisting of cash and stock. EBR is an electric boat rental company operating at Lido Marina Village in Newport Beach, California. EBR’s business is a high margin, profitable and rapidly growing electric rental boat operation which will provide Vision Marine the unique opportunity to showcase its disruptive electric technology and grow its brand recognition. Moreover, EBR represents a template...

Continue reading

Honey Badger Silver Closes Yukon Silver Asset Purchase

TORONTO, June 08, 2021 (GLOBE NEWSWIRE) — Honey Badger Silver Inc. (TSX-V: TUF) (“Honey Badger Silver” or the “Company”) is pleased to announce that it has closed its previously announced transaction with Strategic Metals Ltd. (“Strategic Metals”; TSX-V: SMD) to acquire a 100% interest in the following three silver-focused advanced properties located in the Yukon Territory, Canada (the “Transaction”): (1) Plata: lies within the Tintina Gold Belt with geology analogous to the prolific Keno Hill silver district,  (2) Groundhog: falls within a belt of high-grade gold occurrences including the Ketza Mine with very high grade silver in rock samples, and  (3) Hy: covers many high-grade silver occurrences first discovered in the 1960’s (for more information on the Properties, please refer to the Company’s news release dated February 11,...

Continue reading

MediPharm Labs Extends Strategic Partnership with ADREXpharma and continues to Build its Presence in Germany

MediPharm and ADREXpharma continue to lead the way addressing rising patient demand in the burgeoning German Medical Cannabis Market that saw sales increase 34% last year128,000 active patients at end of 2020; German patients spent an average of $500EUR per month, finished products and extract sales continue to gain market shareMediPharm and ADREXpharma on track to deliver subsequent shipments to Germany in Q2 2021, completed first shipments in Q1 2021ADREXpharma is Germany’s largest independent privately owned Medical Cannabis company with deep pharma market expertise.TORONTO, June 08, 2021 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a global leader in specialized, research-driven pharmaceutical-quality development and manufacture of cannabis API and...

Continue reading

QIWI Appoints Chief Executive Officer

NICOSIA, Cyprus, June 08, 2021 (GLOBE NEWSWIRE) — QIWI plc (NASDAQ: QIWI) (MOEX: QIWI) (“QIWI” or the “Company”), a leading provider of next generation payment and financial services in Russia and the CIS, today announced the appointment of Andrey Protopopov as Chief Executive Officer effective June 2, 2021. As Chief Executive Officer, Mr. Protopopov will take over the responsibilities of Boris Kim. Mr. Protopopov has long played a vital role at QIWI, in particular, its product development function. Prior to his current position as the Chief Executive Officer of Payment Services Segment, Mr. Protopopov has served as Head of IT and Product from June 2015 to August 2019 and Head of Product Management from September 2013 to June 2015. Mr. Protopopov has over 12 years of commercial and product managing experience. Before joining QIWI,...

Continue reading

Aurora Spine Corporation to Present at the Lytham Partners Summer 2021 Investor Conference

CARLSBAD, Calif., June 08, 2021 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will participate in the Lytham Partners Summer 2021 Investor Conference from June 14-16. Aurora’s President and CEO Trent Northcutt, will deliver the company’s investor presentation on Monday, June 14, 2021 at 12:30pm ET. A webcast of the presentation will be available on the Company’s website at www.aurora-spine.com or https://www.webcaster4.com/Webcast/Page/2422/41451. The webcast will be archived and available for replay following the live event. Mr. Northcutt and Mr. Chad Clouse, CFO of Aurora Spine, will also be available for one-on-one meetings throughout the event, which...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.